Your browser doesn't support javascript.
loading
Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy.
Iluta, Sabina; Pasca, Sergiu; Gafencu, Grigore; Jurj, Ancuta; Terec, Andreea; Teodorescu, Patric; Selicean, Cristina; Jitaru, Ciprian; Preda, Alexandra; Cenariu, Diana; Constantinescu, Catalin; Iordache, Maria; Tigu, Bogdan; Munteanu, Raluca; Feder, Richard; Dima, Delia; Zdrenghea, Mihnea; Gulei, Diana; Ciuleanu, Tudor-Eliade; Tomuleasa, Ciprian.
Afiliação
  • Iluta S; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania.
  • Pasca S; Department of Hematology, Ion Chiricuta Clinical Cancer Center Cluj Napoca, Cluj Napoca, Romania.
  • Gafencu G; Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania.
  • Jurj A; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania.
  • Terec A; Department of Hematology, Ion Chiricuta Clinical Cancer Center Cluj Napoca, Cluj Napoca, Romania.
  • Teodorescu P; Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania.
  • Selicean C; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania.
  • Jitaru C; MRC Molecular Haematology Unit - The MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Preda A; Research Center for Functional Genomics and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania.
  • Cenariu D; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania.
  • Constantinescu C; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania.
  • Iordache M; Department of Hematology, Ion Chiricuta Clinical Cancer Center Cluj Napoca, Cluj Napoca, Romania.
  • Tigu B; Department of Leukemia, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, US.
  • Munteanu R; Department of Hematology, Ion Chiricuta Clinical Cancer Center Cluj Napoca, Cluj Napoca, Romania.
  • Feder R; Department of Hematology, Ion Chiricuta Clinical Cancer Center Cluj Napoca, Cluj Napoca, Romania.
  • Dima D; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania.
  • Zdrenghea M; Department of Hematology, Ion Chiricuta Clinical Cancer Center Cluj Napoca, Cluj Napoca, Romania.
  • Gulei D; Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania.
  • Ciuleanu TE; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca, Cluj Napoca, Romania.
  • Tomuleasa C; Department of Hematology, Ion Chiricuta Clinical Cancer Center Cluj Napoca, Cluj Napoca, Romania.
J Cell Mol Med ; 2021 Jun 16.
Article em En | MEDLINE | ID: mdl-34132464
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article